Status:
COMPLETED
Helping Empower Liver and Kidney Patients
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall purpose of this study is to develop and test a web-based decision aid (DA) to support patients with Hepatitis C and Chronic Kidney Disease during decisions about whether, when, and how to ...
Detailed Description
First, for Aim 1, Investigators along with direction from a diverse expert advisory group of nephrologists, hepatologists, and patient partners developed a decision aid based upon International Patien...
Eligibility Criteria
Inclusion
- Must read and understand English AND
- Must have Hepatitis C (any genotype) and Chronic Kidney Disease (any stage)
Exclusion
- Developed jaundice, ascites, variceal hemorrhage, or hepatic encephalopathy also known as Decompensated cirrhosis; or
- Currently has or had liver cancer (Hepatocellular carcinoma); or
- Received a liver transplant
Key Trial Info
Start Date :
September 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03426787
Start Date
September 26 2017
End Date
July 30 2019
Last Update
September 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University in St. Louis School of Medicine
St Louis, Missouri, United States, 63110